Loading...

Intracellular Staining Permeabilization Wash Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL 76€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Peng, Q., Jiang, P., et al. 2025. Gut Microbes. 17(1),2541028. PubMed
  2. Zhang, N., Li, C., et al. 2025. Cell Death Dis. 17(1),115. PubMed
  3. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  4. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  5. Kim S, et al. 2020. Development. 147:00:00. PubMed
  6. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  7. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  8. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  9. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  10. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  11. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  12. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  13. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  14. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  15. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  16. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  17. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  18. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  19. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  20. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  21. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  22. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  23. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  24. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  25. Chan L, et al. 2022. Cells. 12: . PubMed
  26. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  27. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  28. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  29. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  30. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  31. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  32. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  33. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  34. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  35. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  36. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  37. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  38. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  39. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  40. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  41. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  42. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  43. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  44. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  45. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  46. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  47. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  48. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  49. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  50. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  51. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  52. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  53. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  54. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  55. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  56. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  57. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  58. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  59. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  60. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  61. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  62. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  63. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  64. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  65. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  66. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  67. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  68. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  69. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  70. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  71. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  72. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  73. Stewart CA, et al. 2020. bioRxiv. . PubMed
  74. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  75. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  76. Poli V, et al. 2021. iScience. 24:103256. PubMed
  77. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  78. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  79. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  80. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  81. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  82. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  83. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  84. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  85. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  86. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  87. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  88. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  89. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  90. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  91. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  92. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  93. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  94. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  95. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  96. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  97. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  98. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  99. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  100. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  101. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  102. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  103. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  104. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  105. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  106. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  107. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  108. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  109. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  110. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  111. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  112. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  113. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  114. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  115. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  116. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  117. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  118. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  119. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  120. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  121. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  122. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  123. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  124. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  125. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  126. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  127. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  128. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  129. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  130. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  131. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  132. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  133. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  134. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  135. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  136. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  137. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  138. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  139. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  140. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  141. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  142. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  143. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  144. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  145. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  146. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  147. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  148. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  149. Kim S, et al. 2020. Development. . PubMed
  150. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  151. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  152. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  153. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  154. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  155. Ma K, et al. 2022. iScience. 25:104347. PubMed
  156. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  157. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  158. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  159. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  160. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  161. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  162. Lau H, et al. 2020. Islets. 41:12. PubMed
  163. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  164. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  165. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  166. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  167. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  168. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  169. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  170. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  171. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  172. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  173. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  174. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  175. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  176. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  177. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  178. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  179. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  180. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  181. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  182. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  183. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  184. Lee G, et al. 2021. Viruses. 13: . PubMed
  185. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  186. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  187. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  188. Su Y, et al. 2020. Cell. 1479:183. PubMed
  189. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  190. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  191. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  192. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  193. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  194. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  195. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  196. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  197. Wang X, et al. 2022. Elife. 11:. PubMed
  198. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  199. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  200. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  201. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  202. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  203. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  204. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  205. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  206. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  207. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  208. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  209. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  210. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed
  211. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA
Go To Top Version: 3    Revision Date: 08/26/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account